ArticleCureus2025
A Mild Case of Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy With Chronic Onset.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 25-year-old woman presented with mild fever and fatigue that began four months prior to admission. At 30 days after onset, she developed bilateral visual field impairment with hand tremors. Gait difficulty occurred at 60 days after onset. On admission, the patient was alert and well-oriented. Examination revealed central scotomas, papilledema in both eyes, postural tremors in both hands, hyperreflexia in the limbs, positive pathological reflexes in the lower extremities, and spastic gait. Cerebrospinal fluid analysis showed an elevated cell count and protein levels as well as positive glial fibrillary acidic protein (GFAP) α antibodies. Brain magnetic resonance imaging (MRI) revealed hyperintensities in the bilateral cerebral hemispheres and dorsal brainstem on T2-weighted images. These lesions did not show enhancement with gadolinium. Methylprednisolone pulse therapy followed by oral prednisolone led to almost complete resolution of neurological symptoms and MRI abnormalities. Although GFAP astrocytopathy typically presents acutely or subacutely with severe symptoms, it should be considered when patients present with a more chronic course and relatively mild symptoms, as seen in this case. GFAP astrocytopathy should also be considered when patients present with gradually expanding white matter lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.